825 Industrial Road
Suite 500
San Carlos, CA 94070
United States
650 597 5002
https://www.allakos.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 131
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Robert Alexander Ph.D. | CEO & Director | 1,5M | N/D | 1970 |
Dr. Adam L. Tomasi Ph.D. | President | 1,15M | N/D | 1970 |
Mr. Baird Radford III | Chief Financial Officer | 731,35k | N/D | 1970 |
Ms. Mary Cromwell Ph.D. | Chief Technical Officer | N/D | N/D | N/D |
Dr. Chin Lee M.D., M.P.H. | Chief Medical Officer | N/D | N/D | 1970 |
Mr. Alan Chang | Director of Medical Affairs & Data Analytics | N/D | N/D | N/D |
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
L'ISS Governance QualityScore di Allakos Inc. al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 10; diritti degli azionisti: 8; retribuzione: 10.